Saltar al contenido principal

Nanomedicine in Cancer Immunotherapy

  • 1 Edición - 11 de enero de 2024
  • Última edición
  • Editor: Prashant Kesharwani
  • Idioma: Inglés

Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often person… Leer más

Descripción

Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.

This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.

Puntos claves

  • Provides a single source for a review of the latest research in the development of nanomaterials for cancer immunotherapy
  • Introduces the reader to basic principles of immunology and immunotherapy to aid our understanding
  • Details a wide range of nanomaterial classes for cancer immunotherapy, with advantages and disadvantages thoroughly analyzed

De interès para

Researchers and postgraduate students in the fields of materials science, biomedical engineering, pharmaceutical science and nanotechnology, Clinical scientists and R&D groups developing novel materials for biomedical applications

Índice

1. Immunoadjuvants for cancer immunotherapy

2. Nanotechnology as an emerging option in cancer immunotherapy

3. Different administration routes for nanovectors in cancer immunotherapy

4. Two-dimensional materialbased nanomedicines for cancer immunotherapy

5. Hydrogel-based nanomedicines for cancer immunotherapy

6. Exosomes-based nanomedicines for cancer immunotherapy

7. Lipid-based nanomedicines for cancer immunotherapy

8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy

9. Liposome-based nanomedicines for cancer immunotherapy

10. Biomembrane-based nanoparticles for cancer immunotherapy

11. Dendrimer-based nanomedicines for cancer immunotherapy

12. Magnetic nanocarriers for cancer immunotherapy

13. Inhaled delivery of immunotherapy for treatment of lung cancer

14. Nano-based vaccination and their administration routes in cancer immunotherapy

15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 11 de enero de 2024
  • Idioma: Inglés

Sobre el editor

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience across various countries. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has published many articles in well-reputed journals and a large number of books. He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, and “SERB-Ramanujan Fellowship Award”. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

Afiliaciones y experiencia
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India

Ver libro en ScienceDirect

Lee Nanomedicine in Cancer Immunotherapy en ScienceDirect